Tag Archives: post-herpetic neuralgia prevention

GSK Announces EMA Review of Prefilled Syringe Presentation for Shingrix Vaccine

(IN BRIEF) GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix, its recombinant zoster vaccine (RZV) for preventing shingles. This new presentation simplifies administration for healthcare providers by … Read the full press release